CompletedNot Applicable

Hematological Markers in Idiopathic Carpal Tunnel Syndrome

Turkey (Türkiye)70 participantsStarted 2025-04-01

Plain-language summary

Carpal Tunnel Syndrome (CTS) cases are still classified as idiopathic. The rationale of this research is to investigate the role of chronic inflammation and vitamin B12 deficiency in the onset and severity of idiopathic CTS. This case-control study aims to evaluate inflammatory hematological markers and vitamin B12 levels in patients with idiopathic CTS compared to healthy controls, and to analyze their correlation with clinical and electrophysiological severity of the disease

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 18-65 years * Having undergone Electromyography (EMG) testing for Carpal Tunnel Syndrome (CTS)-like symptoms * Recent complete blood count, C-Reactive Protein (CRP), and albumin available Exclusion Criteria: * Age below 18 or above 65 years * Pregnancy * History of wrist trauma or surgical operation * Diabetes mellitus * Chronic kidney disease * Gout * Rheumatoid arthritis * Connective tissue disease * Thyroid disorders * Acromegaly * Polyneuropathy * Thoracic outlet syndrome * Brachial plexopathy * Cervical disc herniation * Presence of cardiac pacemaker * Steroid use

What they're measuring

Evaluation of Systemic Inflammation Response Index (SIRI) as an Inflammatory Marker

Timeframe: up to 4 weeks

Trial details

NCT IDNCT06952647

SponsorAnkara Training and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-15

View on ClinicalTrials.gov More Carpal Tunnel Syndrome (CTS) trials